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Mast cells are known to play a pivotal role in allergic
diseases. Cross-linking of the high-affinity receptor
for IgE (Fc3RI) leads to degranulation and allergic
inflammation; however, the regulatory mechanisms
of IgE-dependent exocytosis remain unknown. We
show here that IkB kinase (IKK) 2 in mast cells plays
critical roles in IgE-mediated anaphylaxis in vivo, and
IgE-mediated degranulation in vitro, in an NF-kB-in-
dependent manner. Upon Fc3RI stimulation, IKK2
phosphorylates SNAP-23, the target membrane
soluble N-ethylmaleimide-sensitive fusion factor
attachment protein receptor (SNARE), and ectopic
expression of a phospho-mimetic mutant of SNAP-
23 partially rescued the impaired IgE-mediated
degranulation in IKK2-deficient mast cells. These re-
sults suggest that IKK2 phosphorylation of SNAP-23
leads to degranulation and anaphylactic reactions.
While this reaction is NF-kB-independent, we addi-
tionally show that IKK2 also regulates late-phase
allergic reactions promoted by the release of proin-
flammatory cytokines in an NF-kB-dependent man-
ner. The findings suggest that IKK2 is a central player
in allergic reactions.
INTRODUCTION
Mast cells are recognized as the major effector cells of the type I
hypersensitivity reactions because of their high-affinity receptors
for IgE (Fc3RI). They are known to play a pivotal role in allergic dis-
eases (Galli et al., 2005a, 2005b), such as atopic rhinitis, asthma,
and atopic dermatitis. Engagement of Fc3RI by IgE, followed by
the aggregation of multiple IgE-bearing Fc3RImolecules by poly-
valent antigen, leads to degranulation, and release of histamine,
LTC4, and other preformed chemical mediators. Additionally,
multiple cytokine genes are transcribed and newly synthesized
arachidonic acid metabolites are secreted, all of which trigger al-
lergic inflammation (Galli et al., 2005a, 2005b). It is well estab-
lished that mast cells mediate the early phase of type I hypersen-
sitivity reactions by releasing granule contents after Fc3RI
crosslinking (Bischoff, 2007). However, the precise regulatory
mechanisms that lead to IgE-dependent exocytosis in mast cellsremain unknown. Furthermore, allergic diseases do not consist
only of early-phase reactions, but also of late-phase reactions
that occur facultatively following early-phase reactions, and are
thought to cause chronic inflammation. Mast cells induce the re-
cruitment of neutrophils by releasing TNF-a and IL-8. In mouse
models, mast cell-secreted TNF-a plays an important role in
late-phase allergic reactions in an NF-kB-dependent manner
(Klemm et al., 2006). The precise role of IkB kinase (IKK) 2 in
mast cells in late-phase allergic reactions remains unknown.
Soluble N-ethylmaleimide-sensitive fusion factor attachment
protein receptor (SNARE) proteins play a central regulatory role
in exocytosis by promoting vesicle fusion with the plasma mem-
brane (Jahn and Sudhof, 1999). Degranulation requires the asso-
ciation of v-SNAREs and t-SNAREs to form a ternary SNARE
complex that catalyzes membrane fusion. The SNARE complex
brings the two membranes in apposition, a necessary step in
overcoming the energy barrier required for membrane fusion.
In mast cells, these include syntaxin 4 (Paumet et al., 2000)
and SNAP-23 (Guo et al., 1998) as t-SNAREs, while VAMP-2
(Miesenbock et al., 1998) and VAMP-8 (Paumet et al., 2000)
represent candidates for v-SNAREs. The syntaxin binding pro-
teins Munc18b and Munc18c are also essential for exocytosis
in mast cells (Martin-Verdeaux et al., 2003). It has been shown
that phosphorylation of SNAP-23 modulates exocytosis (Lin
and Scheller, 2000; Marash and Gerst, 2001; Hepp et al.,
2005). Although protein kinase C can phosphorylate SNAP-23
in vitro, it has not been established as to which kinase phosphor-
ylates SNAP-23 in vivo and regulates exocytosis in mast cells
(Hepp et al., 2005).
Transcription factors of the NF-kB family regulate hundreds of
genes in the context of multiple important biological processes,
such as apoptosis, proliferation, innate and adaptive immune re-
sponses, and inflammation (Hayden and Ghosh, 2004; Li and
Verma, 2002). The IKK complex coordinates the response to
most of the external signals leading to the induction of NF-kB-
activated gene transcription. The activity of the IKK complex re-
sides in two catalytic subunits, IKK1 (also called IKK a) and IKK2
(also called IKK b), and two regulatory subunits, NEMO and ELKs
(Hayden and Ghosh, 2004; Li and Verma, 2002; Scheidereit,
2006; Perkins, 2007). Interestingly, IKK2 is themajor cytokine-re-
sponsive IkB kinase and, thus, is a central component of the in-
tracellular signaling pathway mediating NF-kB activation (Schei-
dereit, 2006; Perkins, 2007). We report that IKK2 in mast cells
plays a critical role in IgE-mediated anaphylaxis in vivo and
IgE-mediated degranulation in vitro in an NF-kB-independent
manner. IKK2 is recruited into the lipid raft fractions andCell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc. 485
Figure 1. Severe Impairment of Anaphylactic Responses in the
Absence of IKK2
(A) PCA in WT or IKK2/ mast cell-reconstituted W/Wv mice was performed
as described in the Experimental Procedures. Ear swelling was quantified by
three consecutive measurements of ear thickness with a caliper before (base-
line) and 1, 2, 3, and 4 hr after antigen challenge. Data are means ± SD from
eight independent experiments. Results show a severe impairment of anaphy-
lactic shock; *p < 0.01.
(B) Upon antigen challenge, leakage of injected Evans blue dye into the ear is
severely decreased in IKK2/ FLMC transplanted mice. Representative data
from eight independent experiments are shown.
(C) Vascular leakage assayed by EB extravasation into ear tissues. Inner ear
rims were removed 90 min after i.v. challenge with antigen with EB, or EB486 Cell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc.phosphorylates SNAP-23 at Ser120 and Ser95 upon Fc3RI stim-
ulation, leading to upregulation of IgE-mediated degranulation in
mast cells. The late-phase allergic reactions initiated by release
of proinflammatory cytokines is also regulated by IKK2 kinase,
but requires NF-kB activity. We conclude that IKK2 kinase regu-
lates both the early- and late-phase allergic reactions.
RESULTS
Severe Impairment of Anaphylactic Responses in the
Absence of IKK2
To investigate the role of IKK2 on anaphylactic responses in vivo,
we used mast cell knock-in mouse model (Galli et al., 2005a,
2005b). FLMCs were generated from Days 11.5–12.5 embryonic
liver of wild-type (WT) or IKK2-deficient (IKK2/) mice because
of the lethality in the IKK2/ embryos at E14 (Li et al., 1999a).
The total number of fetal liver cells was not distinguishable be-
tween WT and IKK2/ mice (WT [4.65 ± 0.34 3 105] versus
IKK2/ [4.24 ± 0.44 3 105]; n = 10). Liver cells isolated from
both genotypes proliferated and expanded normally when cul-
tured in the presence of 100 ng/ml IL-3. After 4 weeks, more
than 98% of cells were c-kit positive, and the number of mast
cells (c-kit+IgE+ cells) recovered per mouse was indistinguish-
able between these mice (see Figure S1A available online). We
confirmed the lack of IKK2 expression of fetal liver-derived
mast cells (FLMCs) from IKK2/mice (Figure S1B). The expres-
sion levels of c-kit and Fc3RIa were also indistinguishable
(Figure S1C). The WT and IKK2/ FLMC were morphologically
indistinguishable by electron microscopy (Figure S1D). Espe-
cially, there was no significant difference in the number of gran-
ules (Figure S1D: WT [40.4 ± 5.4] versus IKK2/ [41.3 ± 4.4]; n =
40) and the mean of granule intensity (Figure S1D: WT [93.4 ±
22.4] versus IKK2/ [92.1 ± 18.6]; n = 40) in each mast cell.
The number of granules in each mast cell was counted and the
density of individual granules was measured and analyzed with
Image J software (NIH, Bethesda, MD). Furthermore, most of
WT and IKK2/ FLMCs were annexin-V- and 7-AAD-negative
(Figure S1E). IgE-induced Ca2+ flux was also normal in IKK2/
FLMCs (Figure S2). These results indicate that IL-3-induced
mast cell development in vitro is not dependent on IKK2 activity.
To generate mast cell knock-in mice, cultured FLMCs were
transplanted intradermally (i.d.) or intravenously (i.v.) into mast
cell-deficient WBB6F1-Kitw/Kitw-v (W/Wv) mice. Four weeks after
transplantation, we examined IgE-dependent anaphylactic reac-
tions in mast cell-reconstituted mice. Antigen challenge of mice
that had been sensitized previously with monoclonal DNP-spe-
cific IgE antibody demonstrated that IKK2/ FLMC-reconsti-
tuted mice exhibited reduced cutaneous anaphylaxis compared
with theWTFLMC-reconstitutedmice, as assessed by change in
ear thickness (Figure 1A) and leakage of injected Evans blue dye
only, and subsequently extracted in formamide. Plots show mean optical
density at 620 nm ± SD; *p < 0.01.
(D) PSA in WT or IKK2/ mast cell-reconstituted W/Wv mice was performed
as described in the Experimental Procedures and monitored by measuring
rectal temperature several times following antigen challenge. Data are mean
± SD from eight independent experiments. Data shown in Figure 1D demon-
strate decrease in systemic anaphylaxis in mice injected with IKK2/ mast
cells; *p < 0.01.
Figure 2. IKK2 Plays Critical Roles in Mast Cell Degranulation
(A) IgE-induced b-hexosaminidase release is impaired in IKK2/ FLMCs.
FLMCs were incubated with anti-TNP IgE for 2 hr and then surface IgE was
cross-linked with (black columns) or without (white columns) TNP-BSA. After
30 min, the percentage of specific b-hexosaminidase release was determined
as described in the Experimental Procedures. Data are means ± SD from five
independent experiments. *Significantly different from the mean value of
control group (WT), *p < 0.01.
(B) IgE-induced histamine release is impaired in IKK2/ FLMCs. FLMCs were
incubated with anti-TNP IgE and cross-linked with (black columns) or without
(white columns) TNP-BSA. After 30 min, supernatants and cell lysates were
recovered. Histamine was measured by EIA. Data are means ± SD from five
independent experiments. *Significantly different from the mean value of con-
trol group (WT), *p < 0.01.
(C) A23187-induced b-hexosaminidase release is impaired in IKK2/ FLMCs.
FLMCs were stimulated with (black columns) or without (white columns)
A23187 (500 ng/ml). After 30 min, the percentage of specific b-hexosamini-
dase release was determined as described in the Experimental Procedures.
Data are means ± SD from five independent experiments. *Significantly
different from the mean value of control group (WT), *p < 0.01.
(D) IgE-induced annexin-V binding is decreased in IKK2/ FLMCs. FLMCs
were incubated with anti-TNP IgE and cross-linked with or without TNP-BSA.
After 30min, cellswere stainedwith annexin-V and analyzed by flowcytometry.
Representative FACS profiles from five independent experiments are shown.
(E) Overexpression of IKK2 results in increase of Fc3RI-stimulated b-hexosamin-
idase release. GFP-IKK2, GFP-IKK2KM, or GFP (as control) stably expressing
RBL-2H3 cells were obtained as described in the Experimental Procedures.
IgE-inducedb-hexosaminidasereleasewasperformedasdescribed inFigure2A.
Data aremeans ± SD from five independent experiments. *Significantly different
from the mean value of control group (mock), *p < 0.01. NS, not significant.in the ear (WT [0.848 ± 0.067] versus IKK2/ [0.242 ± 0.081],
optical density at 620 nm; n = 8; p < 0.01) (Figures 1B and 1C).
We also demonstrated similar experiments in the nonreconsti-
tuted W/Wv mice and confirmed lack of anaphylactic reactions
in these mice as previously described (Galli et al., 2005a,
and our unpublished data). Since mast cell numbers in the ear
skin were identical between WT FLMC-reconstituted mice
and IKK2/ FLMC-reconstituted mice (WT [14.6 ± 4.4/mm] ver-
sus IKK2/ [15.6 ± 4.6/mm], n = 8), the diminished anaphylaxis
in IKK2/ FLMC-reconstitutedmicewasmost likely due tomast
cell hyporeactivity to the antigen. We next examined passive
systemic anaphylaxis (PSA) by measuring decrease of body
temperature after antigen challenge. Figure 1Dshowsadecrease
in PSA in the IKK2/ FLMC-reconstituted mice. These data
imply a physiological role of IKK2 in mast cells is to induce
appropriate mast cell degranulation.
IKK2 Plays Critical Roles in Mast Cell Degranulation
To investigate the cellular basis for the diminished in vivo ana-
phylactic reactions in IKK2/ FLMC-reconstituted mice, we
next compared degranulation (release of b-hexosaminidase
and histamine) between FLMCs derived from WT and IKK2/
mice. Consistent with the defect in anaphylactic responses
in vivo, IKK2/ FLMCs showed clear defects in Fc3RI-stimu-
lated b-hexosaminidase release (WT [25.0% ± 5.4%] versus
IKK2/ [14.4% ± 5.8%]; n = 5; p < 0.01) (Figure 2A), and percent
histamine release (WT [37.7% ± 3.5%] versus IKK2/ [10.8% ±
1.1%]; n = 5; p < 0.01) (Figure 2B). IKK2/ FLMCs also showed
defects in calcium ionophore A23187-stimulated b-hexosamini-
dase release (WT [39.8% ± 2.0%] versus IKK2/ [20.1% ±
0.6%]; n = 5; p < 0.01) (Figure 2C). We next determined the
amount of annexin-V specifically bound to mast cell granules ex-
posed after stimulation with Fc3RI (Demo et al., 1999). IKK2/
FLMCs showed reduced annexin-V binding than WT FLMCs
(Figure 2D). We also examined the effect of overexpression of
IKK2 in the mast cells on Fc3RI-stimulated b-hexosaminidase
release. We examined Fc3RIa expression and apoptosis (an-
nexin-V binding) on RBL-2H3 cells stably expressing GFP or
GFP-IKK2 and confirmed no significant difference between
those cells (data not shown). RBL-2H3, a rat basophilic cell line
stably expressing GFP-IKK2 (Figure 2F), resulted in the increase
of Fc3RI-stimulated b-hexosaminidase release (mock [43.8% ±
4.0%] versus IKK2 [63.0% ± 4.8%]; n = 5; p < 0.01)
(Figure 2E). In order to determine whether kinase activity of
IKK2 is required for IKK2-mediated upregulation of Fc3RI-stimu-
lated b-hexosaminidase release (Figure 2E), we examined the
effect of overexpression of IKK2KM, a kinase-inactive mutant
of IKK2 (Mercurio et al., 1997), on Fc3RI-stimulated b-hexosa-
minidase release. Overexpression of IKK2KM (Figure 2F) did
not enhance Fc3RI-stimulated b-hexosaminidase release
(mock [43.8% ± 4.0%] versus IKK2KM [38.1% ± 3.9%]; n = 5)
(Figure 2E). These results suggest that IKK2 modulates
(F) Western blots to assess expression of GFP, GFP-IKK2, or GFP-IKK2KM in
zeocin-resistant RBL-2H3 cells (Figure 2G). Antitubulin blots were used as
loading controls.Cell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc. 487
antigen-induced mast cell degranulation in a kinase activity-
dependent manner.
NF-kB Activation Is Not Essential for Mast Cell
Degranulation
The seminal event in NF-kB activation is the phosphorylation of
IkBs, which ismediated by IKK complex. We therefore examined
the role of NF-kB activation in Fc3RI-induced degranulation.
RBL-2H3 cells stably expressing GFP-tagged IkBa superrepres-
sor (IkBaM) (Karin and Ben-Neriah, 2000) (Figure 3C) and HIV-
3x-kB luciferase/b-galactosidase plasmids. Expression of
IkBaM in the RBL-2H3 cells resulted in the complete inhibition
of NF-kB-dependent promoter activation in response to TNF-
a (Figure 3A). In contrast, IkBaM-expressing RBL-2H3 cells
showed similar levels of Fc3RI-stimulated b-hexosaminidase re-
lease to the control cells (mock [36.2% ± 4.1%] versus IkBaM
[34.7% ± 3.4%]; n = 5) (Figure 3B). Figure 3C shows that IkBaM
is expressed in these cells. It thus appears that Fc3RI-induced
degranulation is independent of NF-kB activation pathway.
Since the IKK complex contains both IKK1/2 kinases, we next
asked if mast cell degranulation requires both kinases. We gen-
erated FLMCs from IKK1/, IKK2/, and IKK1/IKK2/ double
knockout (Li et al., 2000) embryos and assayed for b-hexosamin-
idase activity following Fc3RI-induced degranulation. Figure 3D
shows that release of b-hexosaminidase was impaired in both
IKK2/ and IKK1/IKK2/ FLMCs (WT [25.0% ± 5.4%] versus
IKK1/IKK2/ [13.4% ± 1.7%]; n = 5; p < 0.01) (Figure 3D) to
a much greater extent as compared with IKK1/ FLMCs (Fig-
ure 3D). We thus conclude that IKK2 modulates IgE-induced
degranulation by an NF-kB-independent mechanism.
IKK2 Is Recruited into the Lipid Raft Fractions upon
Fc3RI Stimulation and Associates with SNAP-23
Mast cells contain the molecular machinery that drives mem-
brane fusion during granule exocytosis. Essential to this process
are soluble NSF (N-ehyl-maleimide-sensitive factor) attachment
protein receptor (SNARE) proteins that lie on opposing cellular
membranes to form a stable multimeric complex that catalyzes
fusion (Jahn and Sudhof, 1999). Mast cells express several
plasma membrane-localized SNAREs (Q-SNAREs) that form
part of the exocytotic machinery. Both SNAP-23 (Guo et al.,
1998) and syntaxin 4 (Paumet et al., 2000) have been implicated
in IgE-dependent fusion and are partly localized in lipid rafts, do-
mains of the plasma membrane enriched in sphingolipids, and
cholesterol (Puri and Roche, 2006; Kay et al., 2006; Chamberlain
and Roche, 2001; Salaun et al., 2005). Furthermore, it has been
suggested that, in T cells, IKK1 and IKK2 are recruited to the lipid
rafts at the immune synapse upon TCR activation (Thome and
Tschopp, 2003; Thome, 2004). Therefore, we first examined
the recruitment of IKK2 into the lipid rafts after Fc3RI stimulation.
Consistent with previous reports (Puri and Roche, 2006; Kay
et al., 2006), SNAP-23 and syntaxin 4 were detected in themem-
brane raft fractions before and after Fc3RI stimulation (Figure 4A,
cosedimentation with CTx in fraction 5). Little or no IKK2 was de-
tected in the lipid raft fractions. In contrast, substantially
increased levels of IKK2 were detected in the membrane raft
fractions upon Fc3RI stimulation (Figure 4A), suggesting that
IKK2 colocalizes with SNAP-23 and syntaxin 4 in the lipid rafts488 Cell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc.only after stimulation. We next examined whether IKK2 can as-
sociate with SNAP-23 or syntaxin 4 by coimunoprecipitation
assay. GFP-tagged SNAP-23 was expressed with or without
FLAG-tagged IKK2 in 293T cells and the amount of GFP-tagged
SNAP-23 following imunoprecipitation with anti-FLAG mAb was
evaluated. Anti-GFP mAb coprecipitated FLAG-tagged IKK2
(Figure 4B). In contrast,myc-taggedsyntaxin 4wasnot coprecip-
itated with FLAG-tagged IKK2 (data not shown). Furthermore,
we examined whether IKK2 associates with SNAP-23 in the lipid
raft fractions before and after Fc3RI stimulation. IKK2 and SNAP-
23 coimmunoprecipitated in the raft fractions following Fc3RI
stimulation (Figure 4C). These results suggest that IKK2 associ-
ates with SNAP-23 in the lipid rafts only after Fc3RI stimulation.
IKK2 Phosphorylates SNAP-23 on Ser120 and Ser95
Phosphorylation of SNAP-23 on Ser120 and Ser95 modulates
regulated exocytosis in mast cells (Hepp et al., 2005). We
therefore examined whether SNAP-23 is a substrate for IKK2.
In vitro kinase assays showed that IKK2 phosphorylated
Figure 3. NF-kB Activation Is Not Essential for Mast Cell De-
granulation
(A) IkBaM stably expressing RBL-2H3 cells were obtained as described in the
Experimental Procedures. Cells were transfected with HIV-3x-kB luciferase
and b-galactosidase plasmid by electroporation. After 24 hr, cells were stim-
ulated with (black columns) or without (white columns) TNF-a (10 ng/ml); 6 hr
later, luciferase activity was measured. Data are means ± SD from five inde-
pendent experiments. *Significantly different from the mean value of control
group (mock), *p < 0.01.
(B) Zeocin-resistant cells were incubated with anti-TNP IgE for 2 hr and then
surface IgE was cross-linked with (black columns) or without (white columns)
TNP-BSA. After 30 min, the percentage of specific b-hexosaminidase release
was determined as described in the Experimental Procedures. Data are
means ± SD from five independent experiments.
(C) Western blots to assess expression of GFP, or GFP-IkBaM in zeocin-resis-
tant RBL-2H3 cells (Figures 3A and 3B).
(D) IgE-induced b-hexosaminidase release from IKK2/, IKK1/IKK2/, or
IKK1/ FLMCs. IgE-induced b-hexosaminidase release was performed as
described in Figure 2A. Data are means ± SD from five independent experi-
ments; *p < 0.01. NS, not significant compared to WT.
SNAP-23 (Figure 5A). However, when Ser120, Ser95, or both
were converted to Ala, phosphorylation of recombinant mutant
SNAP-23 (Figure 5B) by IKK2 was substantially attenuated
(Figure 5A), indicating that IKK2 can phosphorylate SNAP-23
at both Ser120 and Ser95 in vitro. To assess whether this phos-
phorylation by IKK2 occurs in vivo, we used phospho-specific
antibodies (Hepp et al., 2005). Consistent with previous report
(Hepp et al., 2005), Ser120 and Ser95 were phosophorylated
upon Fc3RI stimulation in WT FLMCs (Figure 5C). In contrast,
little or no phosphorylation was detected in IKK2/ FLMCs
Figure 4. IKK2 Is Recruited to the Lipid Raft Fractions upon Fc3RI
Stimulation and Associates with SNAP-23
(A) Localization of GM1 (CTx), IKK2, SNAP-23, syntaxin 4, and VAMP-2 in lipid
raft fraction upon Fc3RI stimulation. Cell lysates of unstimulated (only IgE) or
stimulated (IgE + antigen) RBL-2H3 cells were fractionated by sucrose density
gradient ultracentrifugation and blotted with each antibody. Representative
data from five independent experiments are shown.
(B) IKK2 associates with GFP-SNAP-23 when coexpressed in 293T cells by
immunoprecipitation (IP) assay. Representative data from five independent
experiments are shown.
(C) IKK2 associates with SNAP-23 in the lipid raft fractions only after Fc3RI
stimulation. Fraction 5 was solubilized in 1% octylglucoside and subjected
to IP with anti-SNAP-23 antibody. Immunoprecipitants were blotted with
each antibody.(Figure 5C). These results show that SNAP-23 is phosphorylated
by IKK2 at Ser120 and Ser95 in vitro and in vivo, and that IKK2 is
required for IgE-induced phosphorylation of SNAP-23. It has
been reported that the complex of SNAP-23/syntaxin/VAMP is
minimally required for membrane fusion (Weber et al., 1998).
Consistent with previous report (Puri and Roche, 2006), syntaxin
4 and VAMP-2 coimmunoprecipitated with SNAP-23 in the lipid
raft fractions after Fc3RI stimulation in WT, but not IKK2/mast
cells (Figure 5D). It thus appears that IKK2 regulates the forma-
tion of SNARE complex of SNAP-23/syntaxin 4/VAMP-2, result-
ing in the membrane fusions in the mast cells. We also examined
whether VAMP-8 or VAMP-7 is a component of SNARE complex
as v-SNAREs. VAMP-8, but not VAMP-7, was coimmunoprcipi-
tated with SNAP-23 in the lipid raft fractions after Fc3RI stimula-
tion in WT, but not IKK2/, mast cells (Figure 5D). This result
suggests that, in addition to VAMP 2, VAMP-8 is also involved
as v-SNAREs to mediate mast cell degranulation.
Figure 5. IKK2 Phosphorylates SNAP-23 on Ser120 and Ser95
(A) Equal amounts of purified WT and mutant GST-SNAP-23 proteins were in-
cubated with [g-32P]ATP and IKK2 as described in the Experimental Proce-
dures and the reaction was analyzed by SDS-PAGE and PhosphorImager
analysis. Representative data from five independent experiments are shown.
(B) 0.5 mg of purified GST-fused WT or several mutants of SNAP-23 proteins
were submitted to SDS-PAGE and detected with CBB.
(C) IgE-induced phosphorylation of SNAP-23 on Ser120 and Ser95 is impaired
in IKK2/ FLMCs. FLMCs were incubated with anti-TNP IgE and cross-linked
with or without TNP-BSA. Fifteen minutes later, cell lysates were recovered
and analyzed by immunoblot analysis using phosphorylation site specific an-
tibodies. Representative data from five independent experiments are shown.
(D) Fc3RI-induced formation of SNARE complex of SNAP-23/synatxin
4/VAMP-2 is impaired in IKK2/ mast cells. Cell lysates of unstimulated
(only IgE) or stimulated (IgE + antigen) FLMCs were fractionated by sucrose
density gradient ultracentrifugation. Lipid raft fraction 5 was solubilized in
1% octylglucoside and subjected to IP with anti-SNAP-23 antibody. Immuno-
precipitants were blotted with each antibody.Cell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc. 489
Figure 6. Phosphorylation of SNAP-23 on Ser120 and Ser95 Involved in IKK2-Mediated Degranulation
(A) Western blots to assess expression of SNAP-23 in puromycin-resistant RBL-2H3 cells.
(B) IgE-induced b-hexosaminidase release is impaired in SNAP-23 shRNA-expressing mast cells. SNAP-23 shRNA stably expressing RBL-2H3 cells were
obtained as described in the Experimental Procedures. IgE-induced b-hexosaminidase release was performed as described for Figure 2A. Data are means ±
SD from five independent experiments; *p < 0.01; NS, not significant.
(C) Overexpression of IKK2 does not enhance IgE-induced b-hexosaminidase release in SNAP-23 shRNA-expressing mast cells. SNAP-23 shRNA and/or GFP-
IKK2 stably expressing RBL-2H3 cells were obtained as described in the Experimental Procedures. U6 or GFP indicate control. IgE-induced b-hexosaminidase
release was performed as described in Figure 2A. Data are means ± SD from five independent experiments; *p < 0.01; NS, not significant.
(D) Transduction of SNAP-23 shRNA-resistant SNAP-23 rescues IgE-induced b-hexosaminidase release in SNAP-23 shRNA-expressing mast cells. SNAP-23
shRNA, and FLAG-R-SNAP23 or FLAG-R-SNAP23AA, stably expressing RBL-2H3 cells were obtained as described in the Experimental Procedures. U6 or
FLAG indicate control. IgE-induced b-hexosaminidase release was performed as described in Figure 2A. Data are means ± SD from five independent
experiments *p < 0.01; NS, not significant.
(E) Overexpression of IKK2 enhances IgE-induced b-hexosaminidase release in SNAP-23 shRNA and SNAP-23 shRNA-resistant WT SNAP-23, but not SNAP-23
shRNA and SNAP-23 shRNA-resistant SNAP-23AA-expressing mast cells. SNAP-23 shRNA, GFP-IKK2, and FLAG-R-SNAP23 or FLAG-R-SNAP23AA stably
expressing RBL-2H3 cells were obtained as described in the Experimental Procedures. GFP indicates control. IgE-induced b-hexosaminidase release was
performed as described in Figure 2A. Data are means ± SD from five independent experiments.
(F) Expression of phosphomimetic mutant of SNAP-23 partially rescue the impairment of Fc3RI-induced b-hexosaminidase release in IKK2/mast cells. FLMCs
were infected with retroviruses of pMX-puro-FLAG-WT SANP-23, pMX-puro-FLAG-SNAP-23EE, or pMX-puro (mock). After selection with puromycin, IgE-
induced b-hexosaminidase release was performed as described in Figure 2A. Data are means ± SD from five independent experiments; *p < 0.01; NS, not
significant compared to mock-infected IKK2/ FLMCs.
(G) Mock vector transduced WT FLMCs, and mock vector, WT SNAP-23, or SNAP-23EE transduced IKK2/ FLMCs were injected i.d. in the right ear of W/Wv
mice. After 4 weeks, PCA was performed as described in the Experimental Procedures. Ear swelling was quantified by three consecutive measurements of ear490 Cell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc.
Phosphorylation of SNAP-23 Is Crucial for
IKK2-Mediated Degranulation
To examine the effects of SNAP-23 depletion or expression of
phosphorylation mutant of SNAP-23 on IKK2-induced upregula-
tion of Fc3RI-stimulated b-hexosaminidase release, we gener-
ated several RNAi interference (shRNA) constructs capable of
silencing the expression of SNAP-23 (Figure S3). We selected
RBL-2H3 cells stably expressing shSNAP-23 and consequently
lack of SNAP-23 expression (Figure 6A). Figure 6B shows that
Fc3RI-stimulated b-hexosaminidase release was impaired in
shSNAP-23-expressing cells (mock [42.8% ± 3.2%] versus
shSNAP-23 [29.1% ± 3.4%]; n = 5, p < 0.01). We next examined
the effect of depletion of SNAP-23 on IKK2-induced upregulation
of Fc3RI-stimulated b-hexosaminidase release. In RBL-2H3 cells
stably expressing shSNAP-23 and/or GFP-IKK2 (Figure S4A)
expression of IKK2 resulted in the enhancement of Fc3RI-stimu-
lated b-hexosaminidase release (U6 + GFP [38.4% ± 2.0%] ver-
sus U6 +GFP-IKK2 [59.3% ± 4.2%]; n = 5; p < 0.01) (Figure 6C) in
the presence of control shRNA. In contrast, in shSNAP-23-ex-
pressing cells, IKK2-induced enhancement of Fc3RI-stimulated
b-hexosaminidase release was not observed (Figure 6C;
shSNAP-23 + GFP versus shSNAP-23 + GFP-IKK2). This result
indicates that SNAP-23 is involved in IKK2-mediated degran-
ulation. Since IKK2 phosphorylates SNAP-23 at Ser120 and
Ser95 (Figure 5), we next examined the effect of expression of
SNAP-23AA (Ser120 and Ser95mutated to Ala) on IKK2-induced
upregulation of Fc3RI-stimulated b-hexosaminidase release. We
designed (1) shRNA-resistant SNAP23 (R-SNAP23), which has
three nucleotide mutations in siRNA target sequence; and (2)
SNAP-23 shRNA-resistant SNAP23AA by mutating Ser95 and
Ser120 in shRNA-resistant SNAP23 (Figure S4A). Downregula-
tion of Fc3RI-stimulated b-hexosaminidase release by depletion
of SNAP-23 (U6 + FLAG [41.6% ± 3.4%] versus shSNAP23 +
FLAG [28.3% ± 3.0%]; n = 5; p < 0.01) (Figure 6D) was reversed
in shRNA-resistant SNAP-23 (shSNAP23 + FLAG [28.3% ±
3.0%] versus shSNAP23 + FLAG-R-SNAP23 [45.6% ± 2.2%];
n = 5; p < 0.01) (Figure 6D), but not SNAP-23 shRNA-resistant
SNAP23AA-expressing cells (shSNAP23 + FLAG [28.3% ±
3.0%] versus shSNAP23 + FLAG-R-SNAP23AA [31.2% ±
4.5%]; n = 5) (Figure 6D). We further investigated the effect of
SNAP-23AA on IKK2-induced enhancement of Fc3RI-stimulated
b-hexosaminidase. IKK2-induced enhancement of Fc3RI-stimu-
lated b-hexosaminidase was observed in only SNAP-23 shRNA-
resitant SNAP23 (Figure 6E; shSNAP23 + GFP + FLAG-R-
SNAP23 [43.7% ± 2.3%] versus shSNAP23 + GFP-IKK2 +
FLAG-R-SNAP23 [59.2% ± 7.0%]; n = 5; p < 0.01), but not
SNAP-23 shRNA-resitant SNAP23AA-expressing cells
(Figure S4C) (shSNAP23 + GFP + FLAG-R-SNAP23AA [27.2% ±
4.0%] versus shSNAP23 + GFP-IKK2 + FLAG-R-SNAP23AA
[30.9% ± 2.1%]; n = 5; p < 0.01) (Figure 6E). These results sug-
gest that phosphorylation of SNAP-23 on Ser120 and Ser95 is
required for IKK2-induced upregulation of Fc3RI-stimulated
degranulation. To examine the effect of expression of phos-
phomimetic mutant of SNAP-23 in IKK2/mast cells on Fc3RI-
stimulated b-hexosaminidase release and in vivo early-phasepassive cutaneous anaphylaxis (PCA) reactions, we generated
phosphomimetic mutant SNAP23EE by mutating Ser95 and
Ser120. IKK2/ FLMCs were infected with retroviruses of
pMX-puro-FLAG-WT SNAP-23, pMX-puro-FALG-SNAP23EE,
or pMX-puro (mock), and. as control, WT FLMCs were infected
with mock vectors. All of these cells were selected with puromy-
cin (Figure S5). Ectopic expression of WT SNAP-23 did not res-
cue the impairment of Fc3RI-induced b-hexosaminidase release
in IKK2/ mast cells (Figure 6F: mock [12.4% ± 1.44%] versus
WT SNAP-23 [10.3% ± 0.341%]; n = 8; p < 0.01). By contrast, ex-
pression of SNAP-23EE partially rescued the impairment of
Fc3RI-induced degranulation in IKK2/ mast cells (Figure 6F:
mock [12.4% ± 1.44%] versus SNAP-23EE [18.9% ± 1.11%];
n = 8; p < 0.01). We also examined in vivo early-phase PCA reac-
tions inmast cell-reconstitutedW/Wvmice. Mice withWT SNAP-
23 or mock-transduced IKK2/ FLMCs exhibited similar levels
of reduced cutaneous anaphylaxis (Figure 6G: mock [2.67 ±
1.03 3 102mm] versus WT SNAP-23 [2.33 ± 0.82 3 102mm];
n = 6; p < 0.01), in comparison with mice with control WT FLMCs,
as assessed by change in ear thickness 1 hr after antigen chal-
lenge. By contrast, mice with SNAP-23EE-transduced IKK2/
FLMCs exhibited increased cutaneous anaphylaxis than mice
with mock transduced IKK2/ FLMCs (Figure 6G: mock
[2.67 ± 1.03 3 102mm] versus SNAP-23EE [5.67 ± 1.51 3
102mm]; n = 6; p < 0.01), These results suggest that lack of
phosphorylation of SNAP-23 on Ser120 and Ser95 is responsible
for the impairment of Fc3RI-induced degranulation in IKK2/
mast cells.
Impairment of Late-Phase Allergic Reactions in the
Absence of IKK2
We next examined the late-phase PCA reactions that are
promoted by mast cell-derived proinflammatory cytokines. The
hapten dinitrofluorobenzene (DNFB) challenge of mice that had
been sensitized previously with monoclonal DNP-specific IgE
antibody demonstrated that IKK2/ FLMC-reconstituted mice
exhibited reduced cutaneous anaphylaxis in the WT FLMC-re-
constituted mice, as assessed by challenge in ear thickness
(Figure 7A). Mast cell-secreted TNF-a plays an important role
in late-phase allergic reactions. As such, we next examined
Fc3RI- or A23187-induced TNF-a secretion from IKK2/
FLMCs. Consistent with the defect of late-phase allergic reac-
tions in vivo, IKK2/ FLMCs showed clear defects in Fc3RI-in-
duced (Figure 7B: WT [126.5 ± 9.0 pg/ml] versus IKK2/ 24.9
± 8.8 pg/ml]; n = 5; p < 0.01), and A23187-induced TNF-a secre-
tion (Figure 7C: WT [273.8 ± 8.7 pg/ml] versus IKK2/ [50.8 ±
7.5 pg/ml]; n = 5; p < 0.01). It has been reported that NF-kB ac-
tivation is critical for Fc3RI-induced TNF-a secretion (Klemm
et al., 2006). Therefore, we next examined the effect of overex-
pression of IKK2 or IkBaM in the mast cells on Fc3RI-stimulated
TNF-a secretion. RBL-2H3 stably expressing GFP-IKK2 resulted
in the increase of Fc3RI-stimulated TNF-a release (mock [50.8 ±
7.6 pg/ml] versus GFP-IKK2 [70.9 ± 5.0 pg/ml]; n = 5; p < 0.01)
(Figure 7D). On the other hand, RBL-2H3 stably expressing
GFP-IkBaM resulted in the diminished secretion of TNF-a uponthickness with a caliper before (baseline) and 1 hr after challenge. Data are means ± SD from six independent experiments; *p < 0.01; NS, not significant
compared to mock-infected IKK2/ FLMC-reconstituted mice.Cell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc. 491
Figure 7. Impairment of Late-Phase Allergic Reactions in the
Absence of IKK2
(A) Late-phase PCA reactions in WT or IKK2/mast cell-reconstituted W/Wv
mice were performed as described in the Experimental Procedures. Ear swell-
ing was quantified by three consecutive measurements of ear thickness with
calipers before (baseline) and indicated time after hapten challenge. Data
are means ± SD from six independent experiments. Data demonstrate de-
crease in late-phase PCA reactions in mice injected with IKK2/ mast cells.
(B) IgE-induced TNF-a release is impaired in IKK2/ FLMCs. FLMCs were in-
cubated with anti-TNP IgE and cross-linked with (black columns) or without
(white columns) TNP-BSA; 6 hr later, TNF-a in the supernatants was quantified
by ELISA. Data are means ± SD from five independent experiments. *Signifi-
cantly different from the mean value of control group (WT), *p < 0.01.
(C) A23187-induced TNF-a release is impaired in IKK2/ FLMCs. FLMCs
were stimulated with (black columns) or without (white columns) A23187
(500 ng/ml); 6 hr later, TNF-a in the supernatants was quantified by ELISA.
Data are means ± SD from five independent experiments. *Significantly differ-
ent from the mean value of control group (WT), *p < 0.01.
(D) GFP-IKK2, GFP-IkBaM, or GFP stably expressing RBL-2H3 cells were
obtained as described in the Experimental Procedures. Cells were incubated492 Cell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc.Fc3RI stimulation (mock [50.8 ± 7.6 pg/ml] versus GFP-IkBaM
[16.4 ± 3.7 pg/ml]; n = 5; p < 0.01) (Figure 7D). These results in-
dicate that IKK2-NF-kB signaling pathway plays critical roles in
Fc3RI-induced TNF-a secretion from mast cells, resulting in
late-phase allergic reactions. It is well known that the exocytotic
process is also important to TNF-a secretion. Therefore, our re-
sults suggest that IKK2 can influence both SNAP23- (exocytosis)
and NF-kB-dependent (transcription of TNF-amRNA) pathways
to regulate TNF-a release, respectively, during mast cell activa-
tion induced by Fc3RI aggregation.
DISCUSSION
We have shown that IKK2 promotes IgE-induced degranulation
from mast cells by phosphorylating SNAP-23. First, we found
that IKK2 plays a critical role in the induction of anaphylaxis
in vivo (Figure 1). Second, we observed that IKK2 also plays
a central regulatory role in IgE-induced degranulation by an
NF-kB-independent mechanism (Figures 2 and 3). Third, we
found that IKK2 is recruited into lipid raft fractions upon Fc3RI
stimulation (Figure 4A) and phosphorylates SNAP-23 at Ser120
and Ser95 (Figures 5A and 5C). Finally, depletion of SNAP-23
expression by RNAi (shRNA) prevented IKK2-mediated upregu-
lation of IgE-induced degranulation, and expression of the phos-
phorylation mutant of SNAP-23 (SNAP-23SSAA) also prevented
IKK2-mediated upregulation of IgE-induced degranulation (Fig-
ure 6). These results indicate that IKK2-induced SNAP-23 phos-
phorylation is a key event in SNARE complex formation, leading
to IgE-induced degranulation in mast cells.
Phosphorylation of IkB proteins by IKK complex, containing
the catalytic kinases IKK1 and IKK2, and the regulatory, nonen-
zymatic scaffold proteins NEMO and ELKS, is an essential pro-
cess to activate NF-kB proteins (NF-kB1, NF-kB2, RelA, c-Rel,
and RelB). IKK2 is the major cytokine-responsive IkB kinase,
while IKK1 is involved in noncanonical pathway (Hayden and
Ghosh, 2004), and may also function as a repressor of NF-kB
signaling in some cells (Lawrence et al., 2005; Li et al., 2005; Cor-
rea et al., 2005), We show that Fc3RI-stimulated b-hexosamini-
dase release is clearly impaired in IKK2/ FLMCs, but not in
IKK1-deficient FLMCs. Consistent with our results, Peng et al.
(2005) have demonstrated that inhibition of IKK2 by sulindac,
which is a selective inhibitor of NEMO, resulted in the decrease
of IgE-stimulated histamine release from mast cells. We were
surprised to find that IkBaM, which is a superrepressor of
NF-kB activation, does not have any significant effect on IgE-
induced degranulation (Figure 3B), suggesting that IKK2 modu-
lates IgE-induced degranulation by an NF-kB-independent
mechanism. This is perhaps one of the very few cases where
IKK2 functions in an NF-kB-independent manner, and opens
the possibility that IKK2 may have additional substrates.
We have shown that NF-kB activation is not essential for mast
cell degranulation (Figure 3B). Klemm et al. (2006) have also
with anti-TNP IgE, and cross-linked with (black columns) or without (white col-
umns) TNP-BSA; 6 hr later, TNF-a in the supernatants was quantified by
ELISA. Data are means ± SD from five independent experiments. *Significantly
different from the mean value of control group (WT), *p < 0.01.
shown the defect of NF-kB activation and normal degranulation
in Bcl10/ or Malt1/ mast cells upon Fc3RI stimulation. Their
results are consistent with ours, because only IKK complex, but
not NF-kB, is activated in Bcl10/ T cells upon antigen receptor
activation, suggesting that IKK2 can induce degranulation in the
absence of NF-kB activation (Shambharkar et al., 2007). The
mechanism of antigen receptor-induced IKK complex activation
is, however, still not fully understood, and requires further
investigation.
Like TCR (Thome and Tschopp, 2003; Thome, 2004) or BCR
(Thome, 2004), IKK2 is recruited into lipid rafts upon Fc3RI stim-
ulation (Figure 4A). However, antigen receptor-induced activa-
tion of IKK2 leads to NF-kB activity, resulting in the induction
of the genes that regulate proliferation, cytokine production,
and isotype switching (for B cells) (Li and Verma, 2002). In con-
trast, IKK2 associates with SNAP-23, highly enriched in lipid
raft fractions only after Fc3RI stimulation (Figure 4A). More im-
portantly, this association with SNAP-23 in lipid rafts leads to
the phosphorylation of SNAP 23 at Ser95 and Ser120, essential
for SNARE complex formation and degranulation (Figures 5B
and 5C; Hepp et al., 2005). There is increasing evidence that
IKK2 regulates substrates other than IkBs, NF-kBs, or precur-
sors, and mediate additional functions beyond NF-kB activation
(Hu et al., 2004; Lee et al., 2004; Wegener et al., 2006). Most of
the NF-kB-related molecules (IkBa, IkBb, IkBg, NF-kB p105)
have a putative IKK consensus sequences for phosphorylation
(DSJXXS/T), and phosphorylation of these serine residues by
IKK2 is required for subsequent ubiquitination and degradation
(Karin and Ben-Neriah, 2000). Like Bcl10 (Wegener et al., 2006)
or 14-3-3b (Gringhuis et al., 2005), SNAP-23 also contains no
DSJXXS/T motif, which is the target for phosphorylation of
IKK2 substrates. Phosphorylation of SNAP-23 promotes associ-
ation with other SNARE proteins (Puri and Roche, 2006) to form
the SNARE complex, rather than its degradation, more com-
monly observed with other IKK2 substrates. In light of these
observations, we find it not surprising that phosphorylation sites
of SNAP-23 by IKK2 are not identical for a putative IKK consen-
sus sequences for phosphorylation (DSJXXS/T). We propose
that SNAP-23 is highly enriched in lipid raft fractions before/after
stimulation (Figure 5D). In contrast, only small amounts of syn-
taxin 4 or VAMP-2 are present in lipid raft fractions (Puri and
Roche, 2006) (Figure 4A and Figure 5D, lanes 1 and 3). Upon
stimulation, IKK2 is recruited into the lipid raft fractions
(Figure 4A), phosphorylates SNAP-23 at Ser 95 and Ser120,
and now, essentially, most of syntaxin 4 and VAMP-2, the other
two proteins in the SNARE complex, are in these raft fractions
(Figure 5D, lane 2). In IKK2/ cells either Syntaxin 4 or VAMP-
2 can be found in the rafts (Figure 5D, lane 4). SNAP-23 is an-
chored in the membrane by palmitioylation, and, following phos-
phorylation, recruits syntaxin 4 and VAMP-2 to form the SNARE
complex. Thus phosphorylation of SNAP-23 by IKK2 is the key
event in the formation and promotion of vesicle fusion with the
plasma membrane, resulting in the degranulation in mast cells.
Other groups have already shown that recombinant syntaxin 4/
SNAP-23 and VAMP-2 are capable of driving fusion in vitro (Vi-
cogne et al., 2006; Shen et al., 2007). However, these data do
not rule out that SNAP-23 does not require phosphorylation for
SNARE complex formation in vivo, because they demonstratedin vitro membrane fusion assay in which recombinant SNAREs
were reconstituted on the artificial liposomes. We believe that
this assay is suitable to show SNAREpin formation between
some SNAREs, but it is inadequate to examine the molecular
mechanism of translocation of SNAREs into lipid rafts, because,
in many cases, artificial liposome is made without any choles-
terol. Our result (Figure 5D) suggests that phosphorylation of
SNAP-23 by IKK2 is an essential event in the colocalization of
syntaxin 4 and VAMP-2with SNAP-23 in lipid raft fractions during
the exocytotic process. Our data highlight the importance of
IKK2 in anaphylactic reactions, but does not rule out other mech-
anisms.
We have shown the essential role of IKK2 in mast cell degran-
ulation (Figure 2) and early-phase allergic reactions (anaphylac-
tic reactions) (Figure 3). We have also shown that this regulation
by IKK2 is dependent on SNAP-23 (Figure 6), but not NF-kB (Fig-
ure 3). On the other hand, we have shown the important role of
IKK2 in TNF-a release from mast cells and late-phase allergic
reactions (Figure 7). Additionally, we have shown that regulation
of TNF-a secretion by IKK2 is partially dependent on NF-kB ac-
tivation, consistent with a previous report (Klemm et al., 2006).
Taken together, IKK2 in mast cells regulates early-phase allergic
reactions in a SNAP-23-dependent manner, and, in late-phase
allergic reactions, requires both SNAP-23 and NF-kB. Therefore,
IKK2 is a central modulator in allergic reactions.
EXPERIMENTAL PROCEDURES
Mice
IKK1- (Li et al., 1999b) and IKK2 (Li et al., 1999a) -heterozygous mice were
backcrossed for over eight generations onto C57BL/6 mice. Genetically
mast cell-deficient mice, WBB6F1-W/Wv mice (W/Wv mice) were purchased
from The Jackson Laboratory. Mice were bred and housed in the animal
care facility at the Salk Institute. Experimental procedures involving mice fol-
lowed the guidelines from the National Institutes of Health, and were approved
by the Animal Use Committee at the Salk Institute.
Cell Culture
WT, IKK1/, IKK2/, and IKK1/IKK2/ fetal liver cells from Embryonic
Day 11.5–12.5 mice were obtained by removing cells from the liver. Cells
were cultured in RPMI 1640 medium containing 10% heat-inactivated FCS,
50 mM b-mercaptoethanol, 2 mM L-glutamine, antibiotics, and 100 ng/ml mu-
rine-recombinant IL-3 (R&D Systems). More than 98% of cells obtained after
4 weeks of culture were morphologically mast cells (FLMCs) and positive for
c-kit expression. RBL-2H3 cells (CRL-2256 [ATCC]) were grown as monolayer
cultures in Eagle’s minimum essential medium supplemented with 15%
heat-inactivated fetal bovine serum. 293T cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% FCS and antibiotics.
Reconstitution of W/Wv Mice with FLMCs
For reconstitution of skin mast cells of W/Wv mice, 1 3 106 WT or IKK2/
FLMCs in 20 ml of PBS were injected i.d. into the right ear of W/Wv mice; for
control, left ears were injected with PBS. For systemic reconstitution of mast
cells of W/Wv mice, 1 3 107 WT or IKK2/ FLMCs, in 100 ml of PBS, were
injected i.v. into W/Wv mice; controls were injected with PBS.
PCA and PSA
To elicit PCA, 4 weeks after FLMC transplantation, mice were first primed with
IgE by intradermal injection in the ears, with 100 ng monoclonal mouse dinitro-
phenol-specific (anti-DNP) IgE (Sigma) in 20 ml of PBS. After 24 hr, mice were
injected i.v. with 200 mg of DNP-HSA (human serum albumin; Sigma) diluted in
sterile 0.9% NaCl. Ear swelling was quantified by three consecutive measure-
ments of ear thickness with a caliper before (baseline) and 1, 2, 3, and 4 hr afterCell 134, 485–495, August 8, 2008 ª2008 Elsevier Inc. 493
antigen challenge. In some experiments, 0.5% Evans blue dye was injected
with DNP-HSA. To elicit PSA, 4 weeks later, FLMCs transplantation, mice
were first primed with IgE by i.v. injection, with 20 mg anti-DNP IgE in 100 ml
of PBS. After 24 hr, mice were injected i.v. with 1 mg of DNP-HSA diluted in
sterile 0.9% NaCl. The systemic anaphylactic response was monitored by
measuring rectal temperature several times after antigen challenge.
Late-Phase Allergic Reactions
To elicit late-phase PCA reactions, 4 weeks after FLMC transplantation, mice
were first primed with IgE by i.v. injection with 20 mg anti-DNP IgE in 100 ml of
PBS. After 24 hr, mice were challenged by epicutaneous application of 10 ml of
DNFB (0.2% w/v) in acetone:olive oil (4:1) to both sides of both ears. The ear
swelling response was assessed by measuring the ear thickness with caliper
before (baseline) and 2, 4, 6, 8, 12, 24, and 48 hr after hapten challenge. The
increment of ear thickness (postchallenge value  prechallenge baseline
value) was expressed as the percent of the baseline value.
Data Analysis
Data are summarized as mean ± SD. The statistical analysis of the results was
performed by the unpaired t test; p values < 0.05 were considered significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and are available with this article online at http://www.cell.com/cgi/
content/full/134/3/485/DC1/.
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